🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/03/1992 | 23,46 | 23,48 | 23,10 | 23,20 | -1,44% | 1,61% | 5.392.589 |
| 26/03/1992 | 23,87 | 23,89 | 23,50 | 23,54 | -1,33% | 1,67% | 3.335.784 |
| 25/03/1992 | 23,93 | 24,07 | 23,82 | 23,86 | +0,00% | 1,08% | 4.551.254 |
| 24/03/1992 | 23,54 | 23,89 | 23,42 | 23,86 | +1,87% | 2,03% | 4.421.093 |
| 23/03/1992 | 23,40 | 23,48 | 23,22 | 23,42 | +0,09% | 1,10% | 3.749.534 |
| 20/03/1992 | 23,56 | 23,60 | 23,24 | 23,40 | -0,76% | 1,52% | 7.965.010 |
| 19/03/1992 | 23,66 | 23,68 | 23,50 | 23,58 | +0,17% | 0,76% | 2.943.413 |
| 18/03/1992 | 23,80 | 23,89 | 23,54 | 23,54 | -1,17% | 1,50% | 3.493.613 |
| 17/03/1992 | 23,48 | 23,84 | 23,48 | 23,82 | +1,53% | 1,52% | 3.963.326 |
| 16/03/1992 | 23,48 | 23,50 | 23,22 | 23,46 | -0,17% | 1,19% | 4.264.522 |
| 13/03/1992 | 23,66 | 23,70 | 23,22 | 23,50 | +0,17% | 2,02% | 5.477.477 |
| 12/03/1992 | 23,87 | 23,91 | 23,34 | 23,46 | -1,91% | 2,41% | 6.167.899 |
| 11/03/1992 | 24,09 | 24,15 | 23,86 | 23,91 | -1,15% | 1,24% | 3.617.486 |
| 10/03/1992 | 24,07 | 24,33 | 24,07 | 24,19 | +0,50% | 1,07% | 4.820.381 |
| 09/03/1992 | 23,89 | 24,17 | 23,89 | 24,07 | +0,92% | 1,16% | 4.049.472 |
| 06/03/1992 | 24,07 | 24,21 | 23,78 | 23,86 | -0,83% | 1,82% | 5.312.731 |
| 05/03/1992 | 24,01 | 24,31 | 24,01 | 24,05 | +0,00% | 1,24% | 5.025.370 |
| 04/03/1992 | 24,47 | 24,49 | 23,84 | 24,05 | -1,71% | 2,68% | 8.561.741 |
| 03/03/1992 | 24,95 | 24,97 | 24,47 | 24,47 | -1,91% | 1,99% | 4.655.006 |
| 02/03/1992 | 25,05 | 25,13 | 24,87 | 24,95 | -0,48% | 1,03% | 4.001.683 |
| 28/02/1992 | 25,21 | 25,25 | 24,85 | 25,07 | -0,47% | 1,58% | 4.624.824 |
| 27/02/1992 | 25,31 | 25,45 | 25,09 | 25,19 | -0,16% | 1,41% | 7.355.074 |
| 26/02/1992 | 24,63 | 25,33 | 24,49 | 25,23 | +4,02% | 3,39% | 12.049.694 |
| 25/02/1992 | 23,99 | 24,25 | 23,95 | 24,25 | +2,01% | 1,24% | 5.188.858 |
| 24/02/1992 | 23,22 | 23,86 | 23,22 | 23,78 | +2,22% | 2,74% | 4.154.482 |
| 21/02/1992 | 23,46 | 23,62 | 23,02 | 23,26 | -0,68% | 2,54% | 6.984.710 |
| 20/02/1992 | 23,16 | 23,58 | 23,16 | 23,42 | +2,17% | 1,80% | 6.459.662 |
| 19/02/1992 | 23,20 | 23,22 | 22,82 | 22,92 | -1,28% | 1,71% | 8.766.730 |
| 18/02/1992 | 23,74 | 23,86 | 23,22 | 23,22 | -1,52% | 2,68% | 5.784.331 |
| 14/02/1992 | 23,89 | 23,91 | 23,56 | 23,58 | -1,82% | 1,50% | 6.823.738 |